High-dose therapy in patients with Hodgkin’s disease: the use of selected CD34+ cells is as safe as unmanipulated peripheral blood progenitor cells
Blystad, A K, Holte, H, Kvaløy, S, Smeland, E, Delabie, J, Kvalheim, GVolume:
28
Year:
2001
Language:
english
Pages:
9
DOI:
10.1038/sj.bmt.1703244
File:
PDF, 144 KB
english, 2001